Drug Shortage Report for EPHEDRINE SULFATE INJECTION USP
| Report ID | 157408 |
| Drug Identification Number | 00876534 |
| Brand name | EPHEDRINE SULFATE INJECTION USP |
| Common or Proper name | EPHEDRINE SO4 |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | EPHEDRINE SULFATE |
| Strength(s) | 50MG |
| Dosage form(s) | LIQUID |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1ML 10LIAM |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-03-25 |
| Estimated end date | 2022-04-01 |
| Actual end date | 2022-03-30 |
| Shortage status | Resolved |
| Updated date | 2022-03-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-03-31 | English | Compare |
| v5 | 2022-03-30 | French | Compare |
| v4 | 2022-03-30 | English | Compare |
| v3 | 2022-03-26 | English | Compare |
| v2 | 2022-03-25 | French | Compare |
| v1 | 2022-03-25 | English | Compare |
Showing 1 to 6 of 6